TOPCAT: Effects of Spironolactone on CV Outcomes in Patients with Heart Failure with Preserved Ejection Fraction

Article Information

DOI 
http://dx.doi.org/10.1177/155989771320006
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2013 MD Conference Express®

Author Information

  1. Mary Mosley
  1. Marc A. Pfeffer, MD, PhD
    1. Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, USA
View Full Text

Article usage

AbstractFullPDF
Apr 2015711
May 2015200
Jun 2015200
Jul 2015100
Aug 2015111
Sep 2015400
Oct 2015433
Nov 2015400
Total2555

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
TOPCAT: Effects of Spironolactone on CV Outcomes in Patients with Heart Failure with Preserved Ejection Fraction
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Cardiology Clinical Trials
Heart Failure
Cardiology Clinical Trials
Cardiology & Cardiovascular Medicine
Heart Failure